These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36631026)

  • 41. Whole-Genome Sequencing for Resistance Level Prediction in Multidrug-Resistant Tuberculosis.
    Li J; Yang T; Hong C; Yang Z; Wu L; Gao Q; Yang H; Tan W
    Microbiol Spectr; 2022 Jun; 10(3):e0271421. PubMed ID: 35658579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic performance of whole-genome sequencing for identifying drug-resistant TB in Thailand.
    Kamolwat P; Nonghanphithak D; Chaiprasert A; Smithtikarn S; Pungrassami P; Faksri K
    Int J Tuberc Lung Dis; 2021 Sep; 25(9):754-760. PubMed ID: 34802498
    [No Abstract]   [Full Text] [Related]  

  • 43. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Shanghai, China.
    Wu X; Gao R; Shen X; Guo Y; Yang J; Wu Z; Tan G; Wang H; Yu F
    Int J Infect Dis; 2020 Jul; 96():48-53. PubMed ID: 32339720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs.
    Phelan JE; O'Sullivan DM; Machado D; Ramos J; Oppong YEA; Campino S; O'Grady J; McNerney R; Hibberd ML; Viveiros M; Huggett JF; Clark TG
    Genome Med; 2019 Jun; 11(1):41. PubMed ID: 31234910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug-Resistant Characteristics, Genetic Diversity, and Transmission Dynamics of Rifampicin-Resistant Mycobacterium tuberculosis in Hunan, China, Revealed by Whole-Genome Sequencing.
    He W; Tan Y; Liu C; Wang Y; He P; Song Z; Liu D; Zheng H; Ma A; Zhao B; Ou X; Xia H; Wang S; Zhao Y
    Microbiol Spectr; 2022 Feb; 10(1):e0154321. PubMed ID: 35171016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of whole genome sequencing and software tools for drug susceptibility testing of Mycobacterium tuberculosis.
    van Beek J; Haanperä M; Smit PW; Mentula S; Soini H
    Clin Microbiol Infect; 2019 Jan; 25(1):82-86. PubMed ID: 29653190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis.
    García-Marín AM; Cancino-Muñoz I; Torres-Puente M; Villamayor LM; Borrás R; Borrás-Máñez M; Bosque M; Camarena JJ; Colomer-Roig E; Colomina J; Escribano I; Esparcia-Rodríguez O; Gil-Brusola A; Gimeno C; Gimeno-Gascón A; Gomila-Sard B; González-Granda D; Gonzalo-Jiménez N; Guna-Serrano MR; López-Hontangas JL; Martín-González C; Moreno-Muñoz R; Navarro D; Navarro M; Orta N; Pérez E; Prat J; Rodríguez JC; Ruiz-García MM; Vanaclocha H; ; González-Candelas F; Furió V; Comas I
    Lancet Microbe; 2024 Jan; 5(1):e43-e51. PubMed ID: 38061383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Whole-genome sequencing of presumptive MDR-TB isolates from a tertiary healthcare setting in Mumbai.
    Zade A; Shah S; Hirani N; Kondabagil K; Joshi A; Chatterjee A
    J Glob Antimicrob Resist; 2022 Dec; 31():256-262. PubMed ID: 36272707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.
    Dang TM; Nguyen TN; Wolbers M; Vo SK; Hoang TT; Nguyen HD; To MH; Vuong MB; Nguyen TP; Tran VQ; Nguyen TB; Vo TH; Nguyen TN; Dai VH; Phan TH; Nguyen HD; Farrar J; Caws M
    BMC Infect Dis; 2012 Mar; 12():49. PubMed ID: 22375832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda.
    Ssengooba W; Meehan CJ; Lukoye D; Kasule GW; Musisi K; Joloba ML; Cobelens FG; de Jong BC
    Infect Genet Evol; 2016 Jun; 40():8-16. PubMed ID: 26917365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of the FluoroType MTBDR Assay for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates.
    Hillemann D; Haasis C; Andres S; Behn T; Kranzer K
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29593055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment.
    Coronel J; Roper MH; Herrera C; Bonilla C; Jave O; Gianella C; Sabogal I; Huancaré V; Leo E; Tyas A; Mendoza-Ticona A; Caviedes L; Moore DA
    Clin Microbiol Infect; 2014 Jun; 20(6):536-41. PubMed ID: 24107197
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of genetic diversity and clonal complexes by whole genome sequencing of Mycobacterium tuberculosis isolates from Jalisco, Mexico.
    Rendón-Bautista LA; Álvarez-Maya I; Sandoval-Díaz M; Villanueva-Arias JC; Ayala-Chavira N; Zenteno-Cuevas R
    Tuberculosis (Edinb); 2021 Jul; 129():102106. PubMed ID: 34218194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Whole genome sequencing of drug-resistant Mycobacterium tuberculosis isolates in Victoria, Australia.
    Dorji T; Horan K; Sherry NL; Tay EL; Globan M; Viberg L; Bond K; Denholm JT; Howden BP; Andersson P
    Int J Infect Dis; 2024 Jan; 138():46-53. PubMed ID: 37967715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Missed phenotypic drug resistance in pediatric tuberculosis: A cause of concern in a resource-limited setting.
    Kashyap B; Jhanjharia S; Saha R; Gomber S
    Indian J Tuberc; 2023; 70 Suppl 1():S59-S64. PubMed ID: 38110261
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using the Quantamatrix Multiplexed Assay Platform System.
    Wang HY; Uh Y; Kim S; Cho E; Lee JS; Lee H
    Ann Lab Med; 2018 Nov; 38(6):569-577. PubMed ID: 30027701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exploration of the diversity of multi-drug resistant Mycobacterium tuberculosis complex in Lagos, Nigeria using WGS: Distribution of lineages, drug resistance patterns and genetic mutations.
    Noorizhab MNF; Zainal Abidin N; Teh LK; Tang TH; Onyejepu N; Kunle-Ope C; Tochukwu NE; Sheshi MA; Nwafor T; Akinwale OP; Ismail AI; Nor NM; Salleh MZ
    Tuberculosis (Edinb); 2023 May; 140():102343. PubMed ID: 37080082
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Park J; Shin SY; Kim K; Park K; Shin S; Ihm C
    Ann Lab Med; 2018 Jul; 38(4):316-323. PubMed ID: 29611381
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tuberculosis-spoligo-rifampin-isoniazid typing: an all-in-one assay technique for surveillance and control of multidrug-resistant tuberculosis on Luminex devices.
    Gomgnimbou MK; Hernández-Neuta I; Panaiotov S; Bachiyska E; Palomino JC; Martin A; del Portillo P; Refregier G; Sola C
    J Clin Microbiol; 2013 Nov; 51(11):3527-34. PubMed ID: 23966495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.